BRIEF published on 04/25/2025 at 14:05, 1 year 6 months ago Bausch Health Unveils Advanced Skin Resurfacing Technology at ASLMS 2025 Bausch Health Aesthetic Medicine Fraxel FTX™ Skin Resurfacing ASLMS 2025
PRESS RELEASE published on 04/25/2025 at 14:00, 1 year 6 months ago Bausch Health Announces Launch of Solta Medical's Fraxel FTX(TM) Bausch Health unveiled Fraxel FTX™, the next-gen skin resurfacing tech, at ASLMS 2025, Orlando. Dual-wavelength laser treats skin concerns with visible results & minimal downtime Bausch Health Laser Technology Skin Resurfacing ASLMS 2025 Fraxel FTX
BRIEF published on 04/22/2025 at 13:30, 1 year 6 months ago Bausch Health Files Supplement to Proxy Statement Amid Icahn's Equity Swaps Proxy Statement Bausch Health Shareholder Rights Equity Swaps Carl Icahn
PRESS RELEASE published on 04/22/2025 at 13:25, 1 year 6 months ago Bausch Health Announces Filing of Supplement to Proxy Statement Bausch Health updates Proxy Statement to disclose 24.6% common shares held by Carl Icahn. Company adopts shareholder rights plan agreement to prevent 'creeping' take-over bids Proxy Statement Bausch Health Update Shareholder Rights Plan Carl Icahn
BRIEF published on 04/17/2025 at 21:45, 1 year 6 months ago Bausch Health Prevails in U.S. District Court Case Bausch Health Norwich Pharmaceuticals XIFAXAN® FDA Ruling Teva Exclusivity
PRESS RELEASE published on 04/17/2025 at 21:40, 1 year 6 months ago U.S. District Court Grants Summary Judgment in Favor of FDA, Salix, and Teva, and Against Norwich Bausch Health and Salix Pharmaceuticals win U.S. District Court case against FDA regarding XIFAXAN, preserving patient access. Company to discuss financial results on April 30 FDA Financial Results Salix Pharmaceuticals XIFAXAN Bausch Health
BRIEF published on 04/14/2025 at 22:35, 1 year 6 months ago Bausch Health Adopts Shareholder Rights Plan Bausch Health TSX Approval Shareholder Rights Plan Take-over Protection Ratification Requirement
PRESS RELEASE published on 04/14/2025 at 22:30, 1 year 6 months ago Bausch Health Announces Adoption of Shareholder Rights Plan Bausch Health implements shareholder rights plan to safeguard fairness in take-over bids. Terms outlined for shareholder ratification within 6 months Bausch Health SRP Shareholder Rights Plan Take-over Bids Shareholder Ratification
BRIEF published on 04/10/2025 at 22:20, 1 year 6 months ago Bausch Health Launches 2025 ASPIRE HIGHER Scholarship Program Bausch Health Higher Education Scholarship Program Dermatologic Conditions 2025 Initiative
PRESS RELEASE published on 04/10/2025 at 22:15, 1 year 6 months ago Bausch Health Announces Ortho Dermatologics 2025 ASPIRE HIGHER Scholarship Program Bausch Health launches 2025 ASPIRE HIGHER Scholarship Program offering $10,000 scholarships to students impacted by dermatologic conditions. Application open until June 11, 2025 Bausch Health Education Scholarships Dermatologic Conditions ASPIRE HIGHER Scholarship Program
Published on 10/30/2026 at 23:35, 1 day 13 hours ago Prospect Ridge Announces Closing of Critical Metals Flow-through Unit Private Placement
Published on 10/30/2026 at 23:30, 1 day 13 hours ago Revolve Enters into Definitive Agreement to Acquire Three Project, 6 MW Battery Storage Portfolio in Ontario
Published on 10/30/2026 at 19:00, 1 day 17 hours ago Electric Royalties Ltd. Announces Application for Warrant Extension
Published on 10/30/2026 at 15:30, 1 day 21 hours ago Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split
Published on 11/01/2026 at 10:35, 2 hours 16 minutes ago Shenzhen Unveils APEC China 2026 Host-City Theme Song and Music Video
Published on 11/01/2026 at 05:00, 7 hours 51 minutes ago 2026 Yangtze River Culture Festival Opens in Yonglian Village, Zhangjiagang, Jiangsu
Published on 10/31/2026 at 16:35, 20 hours 16 minutes ago SKYWORTH Solar Announces Global Launch of Solavita as a Smart Microgrid Brand
Published on 10/30/2026 at 22:49, 1 day 14 hours ago EQS-Adhoc: STRATEC SELLS LOSS-MAKING BUSINESS, RECOGNIZES IMPAIRMENTS, AND AMENDS GUIDANCE
Published on 10/30/2026 at 23:00, 1 day 13 hours ago BIOPHYTIS REPORTS FIRST- HALF 2026 RESULTS AND PROVIDES AN UPDATE ON ITS STRATEGY
Published on 10/30/2026 at 12:00, 2 days ago Capital increase through exercise of subscription rights
